Welsh CRO Simbec goes independent with new investment

CRO Simbec Research is using an investment from the Wales Life Sciences Investment Fund to acquire itself from the Canadian Altasciences Group, looking to expand its staff to more than 100 and chase new development deals around the world. The company isn't disclosing the size of the investment, but the deal is the first for the new fund, which is backed by biotech entrepreneur Sir Chris Evans. News

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

Genae's CEO says the transaction reflects recent focus on digital health and data-driven services.